Regeneron preannounced disappointing U.S. Eylea sales, while Exelixis issued light 2024 guidance. REGN stock and EXEL stock slumped.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Regeneron Slumps As Its Biggest Moneymaker Flops Amid Ongoing Roche Rivalry